On August 23, 2016, a ribbon cutting ceremony was held to celebrate the launch of NewYork-Presbyterian’s second Patient Placement Operations Center (PPOC), located at the NewYork-Presbyterian/Weill Cornell Medical Center campus. The first NewYork-Presbyterian PPOC went live February 2, 2016 at NewYork-Presbyterian/Columbia University Medical Center.

NewYork-Presbyterian, with Columbia University Medical Center and Weill Cornell Medicine, was recognized in the 2016 edition of Becker's Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs, featuring hospitals and health systems leading the nation in cancer care.

Dr. Haviva Veler, director of the Pediatric Sleep and Breathing Disorders Center at Weill Cornell Medicine and pediatrician at NewYork-Presbyterian/Phyllis and David Komansky Center for Children’s Health, offers tips to help get kids back on track to receive sufficient rest.

A vaccine developed at Weill Cornell Medicine and NewYork-Presbyterian to blunt the effects of cocaine has advanced to clinical trials for testing in humans. After demonstrating that the vaccine prevented cocaine from reaching the brain in earlier animal studies, investigators are now enrolling active cocaine addicts in a Phase I randomized control study to test how it works in people.

NewYork-Presbyterian has announced the rollout of NYP OnDemand, a new suite of digital health services designed to improve and expand patient care, while also extending access to the clinical expertise of NewYork-Presbyterian’s physicians to their peers throughout the Hospital’s vast healthcare network. NewYork-Presbyterian is one of the largest, most comprehensive medical institutions in the nation and the only one on this scale to implement an enterprise-wide, comprehensive digital health portfolio.

An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective capture of embolic debris and does not change neurocognitive function for transcatheter aortic valve replacement (TAVR) patients.

A major international study has found that drug-eluting stents, a less-invasive alternative to bypass surgery, is as safe and effective as surgery for most patients with a blockage in the left main coronary artery.

Lipstick Angels, an organization dedicated to providing high quality beauty support services to restore and strengthen the dignity, hope and self-esteem of cancer patients is now expanding its services to New York by aligning with NewYork-Presbyterian/Weill Cornell Medical Center.